Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 36
Filter
1.
Article in English | MEDLINE | ID: mdl-37467259

ABSTRACT

Necrotizing fasciitis is a devastating inflammatory infection requiring emergent medical treatment and surgical intervention. Even with timely management, the mortality rate of necrotizing fasciitis approaches 25%. The causative bacteria invade fascial planes and express toxins that advance rapidly. Here, we document a rare case of necrotizing fasciitis from Serratia marcescens infection. Serratia marcescens is capable of inducing a necrotizing inflammatory cascade mediated by extracellular cytotoxin and lipase. In this case report, a 90-year-old man presented to our emergency department from a long-term care facility with a relatively benign-appearing ulcer with surrounding cellulitis on the right ankle. Blood cultures and wound cultures confirmed the organism to be S marcescens. A multidisciplinary team was consulted for management. The patient received antibiotic therapy and medical support, but because of his comorbid conditions and social situation, the designated medical decision maker opted for comfort care rather than aggressive surgical debridement. The patient progressed through the clinical stages of necrotizing fasciitis. Within 36 hours, the patient died as result of sepsis-induced organ failure.


Subject(s)
Fasciitis, Necrotizing , Serratia Infections , Male , Humans , Aged, 80 and over , Fasciitis, Necrotizing/diagnosis , Fasciitis, Necrotizing/therapy , Fasciitis, Necrotizing/etiology , Ankle , Serratia marcescens , Lower Extremity , Cellulitis , Serratia Infections/diagnosis , Serratia Infections/therapy , Serratia Infections/complications
3.
Nephrology (Carlton) ; 26(3): 255-261, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33150699

ABSTRACT

AIM: To study the epidemiology and clinical outcomes of catheter-related infections of Serratia species in peritoneal dialysis (PD) patients. METHODS: We retrospectively reviewed the patient characteristics, antibiotics susceptibility/resistance patterns and treatment outcomes of exit site infection (ESI) and peritonitis due to Serratia in PD patients during the period of 2004 to 2017. RESULTS: One hundred and sixty-one patients had Serratia ESI, of which 10 (6.2%) progressed to tunnel tract involvement and 11 (6.8%) developed PD peritonitis. Nineteen (11.8%) patients with Serratia ESI failed to respond to medical treatment and required catheter removal. Fifty-six (34.8%) patients had repeat Serratia ESI, which occurred at 12.9 ± 13.6 months after the previous episode. Twenty-two patients had Serratia peritonitis, which accounted for 1% of peritonitis during the study period. Ten (45.5%) patients responded to medical treatment while 12 (54.5%) patients required catheter removal. Nine patients (36.4%) failed to resume PD and were converted to long-term haemodialysis. Two patients had repeat peritonitis at 2 months and 3 years, respectively, after the initial episode. Serratia species in PD patients showed high rates of resistance to ampicillin, and first- and second-generation cephalosporins, but were generally susceptible to aminoglycosides, carboxy-/ureido-penicillins and carbapenems. CONCLUSION: Our results suggest that Serratia ESI show low risk of progression to peritonitis and favourable response to medical therapy, while Serratia peritonitis was associated with high rates of catheter removal and peritoneal failure.


Subject(s)
Anti-Bacterial Agents , Catheter-Related Infections , Kidney Failure, Chronic , Peritoneal Dialysis , Serratia Infections , Serratia/isolation & purification , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/adverse effects , Anti-Bacterial Agents/classification , Catheter-Related Infections/epidemiology , Catheter-Related Infections/microbiology , Catheter-Related Infections/physiopathology , Catheter-Related Infections/therapy , Catheters, Indwelling/adverse effects , Catheters, Indwelling/microbiology , Device Removal/statistics & numerical data , Drug Resistance, Bacterial , Female , Hong Kong/epidemiology , Humans , Kidney Failure, Chronic/epidemiology , Kidney Failure, Chronic/therapy , Male , Middle Aged , Outcome Assessment, Health Care , Peritoneal Dialysis/adverse effects , Peritoneal Dialysis/instrumentation , Peritoneal Dialysis/methods , Peritonitis/epidemiology , Peritonitis/etiology , Serratia Infections/epidemiology , Serratia Infections/etiology , Serratia Infections/physiopathology , Serratia Infections/therapy
4.
BMJ Case Rep ; 13(9)2020 Sep 02.
Article in English | MEDLINE | ID: mdl-32878857

ABSTRACT

An 18-month-old boy presented with lytic lesion of skull and recurrent abscesses with Serratia marcescens The extensive work up revealed a gene mutation confirming the diagnosis of chronic granulomatous disease (CGD). This case scenario underscores the importance of exploring the possibility of immunodeficiency if there is a history of recurrent abscesses with atypical organism. The case also demonstrates that CGD can present as lytic lesion of skull.


Subject(s)
Abscess/immunology , Bone Diseases, Infectious/diagnosis , Granulomatous Disease, Chronic/diagnosis , Serratia Infections/immunology , Serratia marcescens/isolation & purification , Abscess/diagnosis , Abscess/microbiology , Abscess/therapy , Anti-Bacterial Agents/therapeutic use , Antibiotic Prophylaxis , Bone Diseases, Infectious/immunology , Bone Diseases, Infectious/microbiology , Bone Diseases, Infectious/therapy , Craniotomy , Diagnosis, Differential , Frontal Bone/diagnostic imaging , Frontal Bone/immunology , Frontal Bone/microbiology , Frontal Bone/surgery , Granulomatous Disease, Chronic/complications , Granulomatous Disease, Chronic/immunology , Histiocytosis, Langerhans-Cell/diagnosis , Humans , Infant , Magnetic Resonance Imaging , Male , Recurrence , Serratia Infections/diagnosis , Serratia Infections/microbiology , Serratia Infections/therapy , Serratia marcescens/immunology , Tomography, X-Ray Computed
5.
Saudi J Kidney Dis Transpl ; 30(3): 715-718, 2019.
Article in English | MEDLINE | ID: mdl-31249239

ABSTRACT

Dialysis patients have greater number of complications due to multiple comor-bidity and access-related infections as well as nosocomial infections due to reduced immunity and more frequent hospitalizations. Endogenous endophthalmitis is a potentially blinding ocular infection occurring in chronically debilitated patients and the use of invasive procedures. Symmetric peripheral gangrene (SPG) is defined as symmetrical distal ischemic damage in two or more sites in the absence of a major vascular occlusive disease. It carries a high mortality rate with a very high frequency of multiple limb amputations in the survivors. However, only a few case reports have described endogenous endophthalmitis in dialysis patients. Concomitant endophthalmitis and disseminated intravascular coagulation (DIC), presenting as SPG, is extremely rare and no such case was found in the literature survey. Herein, we report a very rare association of bilateral endophthalmitis with DIC and SPG in a patient with chronic kidney disease on maintenance hemodialysis.


Subject(s)
Disseminated Intravascular Coagulation/etiology , Endophthalmitis/etiology , Opportunistic Infections/etiology , Renal Dialysis/adverse effects , Renal Insufficiency, Chronic/therapy , Sepsis/etiology , Serratia Infections/etiology , Disseminated Intravascular Coagulation/diagnosis , Disseminated Intravascular Coagulation/therapy , Endophthalmitis/immunology , Endophthalmitis/microbiology , Endophthalmitis/therapy , Fatal Outcome , Female , Gangrene , Humans , Immunocompromised Host , Middle Aged , Opportunistic Infections/immunology , Opportunistic Infections/microbiology , Opportunistic Infections/therapy , Renal Insufficiency, Chronic/diagnosis , Renal Insufficiency, Chronic/immunology , Sepsis/immunology , Sepsis/microbiology , Sepsis/therapy , Serratia Infections/immunology , Serratia Infections/microbiology , Serratia Infections/therapy , Treatment Outcome
6.
Saudi J Kidney Dis Transpl ; 29(6): 1494-1497, 2018.
Article in English | MEDLINE | ID: mdl-30588985

ABSTRACT

Serratia marcescens (SM) is an opportunistic Gram-negative bacterium. It can cause technique failure or severe sepsis despite being a rare agent causing peritonitis. We present a case of a 40-year-old woman with end-stage renal disease secondary to chronic glomerulo-nephritis on continuous ambulatory peritoneal dialysis (PD). She presented with severe abdominal pain and a cloudy peritoneal fluid. The fluid was cultured according to our unit protocol. The organism isolated was identified as SM; this was after the patient was treated for SM peritonitis one week earlier. The response to treatment with ceftazidime was poor despite being sensitive in vitro. The peritoneal catheter was removed due to rapid clinical deterioration. Piperacillin-tazobactam (PIP/TAZ) monotherapy was successfully administered subsequently. Eventually, she was transferred to hemodialysis (HD). SM is an uncommon cause of PD-related peritonitis. It may cause catheter loss and even death. In our case, the infection could be controlled only after catheter removal, and she was transferred to HD. Cephalosporins should rapidly be changed to PIP/TAZ when SM is isolated from the peritoneal fluid.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Catheter-Related Infections/therapy , Catheters, Indwelling/microbiology , Device Removal , Kidney Failure, Chronic/therapy , Peritoneal Dialysis, Continuous Ambulatory/adverse effects , Peritoneal Dialysis, Continuous Ambulatory/instrumentation , Peritonitis/therapy , Serratia Infections/therapy , Adult , Catheter-Related Infections/diagnosis , Catheter-Related Infections/microbiology , Female , Humans , Kidney Failure, Chronic/diagnosis , Peritonitis/diagnosis , Peritonitis/microbiology , Renal Dialysis , Serratia Infections/diagnosis , Serratia Infections/microbiology , Treatment Outcome
7.
J Am Podiatr Med Assoc ; 107(3): 231-239, 2017 May.
Article in English | MEDLINE | ID: mdl-28650753

ABSTRACT

Serratia marcescens is a ubiquitous, facultatively anaerobic, gram-negative bacillus that has been cited to cause infection in immunocompromised populations. In the literature, S marcescens infections of the lower extremity have presented as granulomatous ulceration, abscess, bullous cellulitis, and necrotizing fasciitis. Herein we present a series of three cases of lower-extremity infections in which S marcescens was the sole or a contributing pathogen. We discuss the commonalities of these three cases as well as with those previously cited. All three patients presented with some combination of a similar set of clinical characteristics, including bullae formation, liquefactive necrosis, and black necrotic eschar. All three patients were diabetic and had peripheral vascular disease.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Lower Extremity/microbiology , Serratia Infections/diagnosis , Serratia marcescens , Aged , Female , Humans , Lower Extremity/pathology , Magnetic Resonance Imaging , Male , Middle Aged , Serratia Infections/complications , Serratia Infections/therapy
9.
Int J Low Extrem Wounds ; 15(2): 161-8, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27079487

ABSTRACT

Serratia marcescens is a Gram-negative bacillus belonging to the Enterobacteriaceae family. Cutaneous infection with Serratia is rare, and usually occurs in immunocompromised individuals. Primary cutaneous infections are uncommon, but they are typically severe and are associated with significant morbidity and mortality. The pathogenetic factors leading to S. marcescens infection are not fully understood, but contributing virulence factors include proteases, secreted exotoxins, and the formation of biofilm. We report a case of cellulitis occurring in a splenectomized patient, which led to multiple wound debridements and a transmetatarsal amputation. This dramatic case led us to review the published literature on soft tissue infections caused by S. marcescens.


Subject(s)
Amputation, Surgical/methods , Cellulitis , Ciprofloxacin/administration & dosage , Fasciitis, Necrotizing , Foot Dermatoses , Serratia Infections , Serratia marcescens/isolation & purification , Splenectomy/adverse effects , Thienamycins/administration & dosage , Aged , Anti-Bacterial Agents/administration & dosage , Biopsy/methods , Cellulitis/etiology , Cellulitis/pathology , Cellulitis/physiopathology , Cellulitis/therapy , Debridement/methods , Fasciitis, Necrotizing/etiology , Fasciitis, Necrotizing/pathology , Fasciitis, Necrotizing/physiopathology , Fasciitis, Necrotizing/therapy , Foot Dermatoses/etiology , Foot Dermatoses/pathology , Foot Dermatoses/physiopathology , Foot Dermatoses/therapy , Humans , Male , Meropenem , Serratia Infections/etiology , Serratia Infections/pathology , Serratia Infections/physiopathology , Serratia Infections/therapy , Skin Diseases, Vesiculobullous/etiology , Skin Diseases, Vesiculobullous/pathology , Skin Diseases, Vesiculobullous/physiopathology , Skin Diseases, Vesiculobullous/therapy , Treatment Outcome
10.
Ann Fr Anesth Reanim ; 33(12): 693-5, 2014 Dec.
Article in French | MEDLINE | ID: mdl-25450727

ABSTRACT

Drug reaction with eosinophilia ans systemic symptoms (DRESS) is a severe medication-induced adverse reaction, which can threaten patient's life. Clinical symptoms and organ failures present wide variability. Furthermore, the latency period is long, so that diagnosis could be a real challenge in the intensive care unit. We report the case of a woman developing a DRESS after neurosurgery complicated by a nosocomial infection.


Subject(s)
Drug Hypersensitivity/therapy , Eosinophilia/therapy , Adult , Anti-Bacterial Agents/adverse effects , Anti-Bacterial Agents/therapeutic use , Cerebral Ventricle Neoplasms/complications , Cerebral Ventricle Neoplasms/surgery , Critical Care , Cross Infection/complications , Cross Infection/therapy , Drug Eruptions , Drug Hypersensitivity/complications , Enterococcus faecalis , Eosinophilia/complications , Exanthema/etiology , Exanthema/therapy , Female , Gram-Positive Bacterial Infections/complications , Gram-Positive Bacterial Infections/therapy , Humans , Serratia Infections/complications , Serratia Infections/therapy
11.
J Emerg Med ; 47(5): 557-60, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25214180

ABSTRACT

BACKGROUND: Skin and soft-tissue infections (SSTIs) are common disease presentations to the emergency department (ED), with the majority of the infections attributed to community-acquired methicillin-resistant Staphylococcus aureus. Rapid and accurate identification of potentially serious SSTIs is critical. Clinician-performed ultrasonography (CPUS) is increasingly common in the ED, and assists in rapid and accurate identification of a variety of disease processes. CASE REPORT: A 21-year-old female presented to the ED with chin swelling and "boils." Although her visual examination was benign, CPUS of her facial swelling quickly established a more concerning disease process, which was eventually confirmed by aspiration and bone biopsy to be mandibular osteomyelitis. The causative organism, Serratia odorifera, is rarely associated with infections, and we are aware of no previously reported cases of osteomyelitis due to this species. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: In this case of mandibular osteomyelitis, CPUS rapidly and accurately identified abnormal bony cortex of the mandible and an associated fluid collection. CPUS of an otherwise benign presentation of a facial infection led to a maxillofacial computed tomography scan, aspiration and biopsy, and then elective debridement of the bone infection. Emergency physicians should be aware of the utility of CPUS and the need to carefully investigate SSTIs presenting to the ED.


Subject(s)
Edema/microbiology , Mandibular Diseases/diagnostic imaging , Osteomyelitis/diagnostic imaging , Serratia Infections/diagnosis , Biopsy , Female , Humans , Mandibular Diseases/microbiology , Osteomyelitis/microbiology , Serratia Infections/complications , Serratia Infections/therapy , Skin Diseases, Bacterial/microbiology , Ultrasonography , Young Adult
12.
J Obstet Gynecol Neonatal Nurs ; 43(5): 625-630, 2014.
Article in English | MEDLINE | ID: mdl-25141908

ABSTRACT

A woman presented for her postpartum examination alarmed about pink stains on her breast pads and on her infant's burp pads and diapers. The stains were also found in her breast pump and the infant's bottles. Out of concern, she stopped breastfeeding. The diagnosis was colonization of mother and infant with Serratia marcescens. They were managed conservatively without antibiotics. The mother was guided to restart breastfeeding. The infant resumed nursing and continued to thrive.


Subject(s)
Breast Feeding/adverse effects , Milk, Human/microbiology , Serratia Infections/diagnosis , Serratia marcescens/isolation & purification , Breast Feeding/methods , Female , Follow-Up Studies , Humans , Postnatal Care , Pregnancy , Rare Diseases , Risk Assessment , Serratia Infections/therapy , Treatment Outcome , Young Adult
14.
J Infect Dev Ctries ; 7(2): 152-4, 2013 Feb 15.
Article in English | MEDLINE | ID: mdl-23416662

ABSTRACT

This study reports a case of Serratia marcescens cellulitis following a snakebite in a 50-year-old woman. The bite was on the dorsum of the right hand with symptoms of envenomation. She developed swelling and cellulitis with tissue necrosis. Wound debridement was performed.  Pus and tissue biopsy cultures yielded Serratia marcescens sensitive to fluoroquinolones, aminoglycosides, third-generation cephalosporins and carbapenems. The patient responded to anti-snake venom (ASV) therapy, ciprofloxacin, local wound management and recovered uneventfully.


Subject(s)
Cellulitis/diagnosis , Cellulitis/microbiology , Serratia Infections/diagnosis , Serratia Infections/microbiology , Serratia marcescens/isolation & purification , Snake Bites/complications , Anti-Bacterial Agents/therapeutic use , Cellulitis/pathology , Cellulitis/therapy , Debridement , Female , Humans , Middle Aged , Serratia Infections/pathology , Serratia Infections/therapy , Serratia marcescens/drug effects
16.
Int J Hyg Environ Health ; 213(2): 79-87, 2010 Mar.
Article in English | MEDLINE | ID: mdl-19783209

ABSTRACT

The following recommendations are derived from a systematic analysis of 34 Serratia marcescens outbreaks described in 27 publications from neonatal and pediatric intensive care units (NICU, PICU), in which genotyping methods were used to confirm or exclude clonality. The clinical observation of two or more temporally related cases of nosocomial S. marcescens infection should raise the suspicion of an outbreak, particularly in the NICU or PICU setting. Since colonized or infected patients represent the most important reservoir for cross transmission, hygienic barrier precautions (contact isolation/cohortation, the use of gloves and gowns in addition to strictly performed hand disinfection, enhanced environmental disinfection) should immediately be implemented and staff education given. Well-planned sampling of potential environmental sources should only be performed when these supervised barrier precautions do not result in containment of the outbreak. The current strategy of empiric antibiotic treatment should be reevaluated by a medical microbiologist or an infectious disease specialist. Empiric treatment of colonized children should use combination therapy informed by in vitro susceptibility data; in this context the high propensity of S. marcescens to cause meningitis and intracerebral abscess formation should be considered. In vitro susceptibility patterns do not reliably prove or exclude the clonality of the outbreak isolate. Genotyping of the isolates by pulse-field gel electrophoresis or PCR-based methods should be performed, but any interventions to interrupt further nosocomial spread should be carried out without waiting for the results.


Subject(s)
Cross Infection/epidemiology , Disease Outbreaks , Intensive Care Units, Neonatal/statistics & numerical data , Serratia Infections/epidemiology , Serratia marcescens , Anti-Bacterial Agents/therapeutic use , Genotype , Humans , Infection Control , Microbial Sensitivity Tests , Risk Factors , Serratia Infections/therapy , Serratia Infections/transmission , Serratia marcescens/genetics
17.
Int J Pediatr Otorhinolaryngol ; 73(3): 467-73, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19081644

ABSTRACT

Necrotizing fasciitis is a rare, life-threatening infection. We report a case of necrotizing oropharyngitis caused by Serratia marcescens in a previously immunocompetent 6-year-old male. This necrotizing infection led to a near-total defect of the oropharynx. The wound was managed with daily wound debridement of the patient's oropharynx with 3% hydrogen peroxide, carotid artery coverage with Kaltostat, and pharyngeal packing with iodoform ribbon gauze. Our patient's resultant nasopharyngeal and hypopharyngeal stenoses present challenges for restoration of form and function for voicing and deglutition. We present our experience of managing this child's hypopharyngeal stenosis with a minimally invasive double-balloon dilatation technique.


Subject(s)
Fasciitis, Necrotizing/pathology , Neck , Pharyngitis/microbiology , Serratia Infections/pathology , Serratia marcescens , Catheterization , Child , Cicatrix/therapy , Constriction, Pathologic/therapy , Fasciitis, Necrotizing/microbiology , Fasciitis, Necrotizing/therapy , Humans , Hypopharynx/pathology , Male , Nasopharynx/pathology , Oropharynx , Pharyngitis/pathology , Pharyngitis/therapy , Serratia Infections/complications , Serratia Infections/therapy
18.
Cornea ; 26(8): 1011-3, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17721309

ABSTRACT

PURPOSE: To report the case of a 70-year-old woman with Serratia infectious crystalline keratopathy. METHODS: Case report. RESULTS: This is a report of a 70-year-old woman with a history of chronic open-angle glaucoma and trachoma with lagophthalmos, entropion, and trichiasis in both eyes who developed crystalline keratopathy after penetrating keratoplasty and cataract extraction in the right eye followed up with treatment with long-term topical steroids. Ten months after the initial penetrating keratoplasty and cataract extraction, the patient had decreased visual acuity, intense pain, and tearing in the right eye. Corneal cultures showed Serratia marcescens. Topical steroids were discontinued, and treatment with tobramycin and vancomycin ophthalmic solution every hour was initiated. Despite 1 week of aggressive therapy, there was an increase in corneal infiltrate, epithelial defects, and melting, which eventually involved the peripheral recipient cornea. Therapeutic penetrating keratoplasty, debridement of the peripheral cornea, and amniotic membrane transplantation were performed. Antibiotic agents were used postoperatively. There has been no evidence of recurrent infection. The best-corrected visual acuity improved to 6/15 at the 6-month follow-up period after the second intervention. CONCLUSIONS: S. marcescens may cause infectious crystalline keratopathy after penetrating keratoplasty in patients treated with long-term topical steroids. Therapeutic penetrating keratoplasty, surgical debridement, and amniotic membrane transplantation may be necessary when the clinical response to intensive medical treatment is inadequate.


Subject(s)
Cornea/microbiology , Corneal Diseases/microbiology , Eye Infections, Bacterial/microbiology , Serratia Infections/microbiology , Serratia marcescens/isolation & purification , Aged , Amnion/transplantation , Anti-Bacterial Agents/therapeutic use , Combined Modality Therapy , Corneal Diseases/diagnosis , Corneal Diseases/therapy , Debridement , Drug Therapy, Combination , Eye Infections, Bacterial/diagnosis , Eye Infections, Bacterial/therapy , Female , Fluorometholone/therapeutic use , Glucocorticoids/therapeutic use , Humans , Keratoplasty, Penetrating , Serratia Infections/diagnosis , Serratia Infections/therapy , Tobramycin/therapeutic use
20.
Adv Perit Dial ; 22: 73-6, 2006.
Article in English | MEDLINE | ID: mdl-16983944

ABSTRACT

Despite a decreasing incidence, peritonitis remains an important cause of peritoneal dialysis (PD) technique failure and transfer to hemodialysis. Infection with Serratia spp. has been suggested to be associated with a poor technique outcome in PD. We examined the data at our center to see if patients with Serratia peritonitis had a similar poor outcome. In this retrospective study, we reviewed all PD patients who presented at our center with peritonitis from January 1996 to December 2003. The case records of patients in whom the infecting organism was identified as Serratia were evaluated. We recorded age at the time of peritonitis and at the start of PD, sex, presence of diabetes mellitus, PD modality at the time of peritonitis, and duration of PD before the onset of peritonitis. For each episode of peritonitis, we recorded the type and duration of antibiotic therapy and the outcome. Over the study period, 52% of all peritonitis episodes involved gram-positive organisms; 29%, gram-negative organisms; and 19%, other organisms. Serratia spp. accounted for 16 episodes (3.68%). These 16 episodes of peritonitis occurred in 12 patients, with 3 repeat infections and 1 relapsing infection. The distribution between the sexes was equal, and the median age at diagnosis was 67 years (range: 37-79 years). Four patients with diabetes accounted for 6 of the 16 episodes (37.5%). In 7 episodes (43.8%), a Serratia exit-site infection preceded the peritonitis. In 4 episodes, catheter removal was required. A fifth patient developed sepsis and died. Technique survival was therefore 68.8% (11 of 16 episodes). We also compared the outcomes of different initial antibiotic regimens. With an initial regimen based on cefazolin-ceftazidime, as suggested in the 2000 guidelines of the International Society for Peritoneal Dialysis, technique survival was 60% (3 of 5 episodes). When the initial regimen included an aminoglycoside, the technique survival was 80% (8 of 10 episodes). Serratia-induced peritonitis was associated with a technique survival of 68.8% at our center.


Subject(s)
Peritoneal Dialysis/adverse effects , Peritonitis/etiology , Serratia Infections/etiology , Adult , Aged , Female , Humans , Male , Middle Aged , Peritonitis/microbiology , Peritonitis/therapy , Serratia Infections/therapy , Survival Analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...